ESR1 and breast carcinoma: We use six of the largest breast cancer cohorts available (described in [4,11,12,18,25,26]; in [4] we used the independent cohort of 101 samples from the John Radcliffe Hospital, Oxford, UK), representing a total of 877 ER+ patients profiled across three different microarray platforms.